Objectives To show the ability of using the amide proton transfer-weighted (APTW) MRI signals as imaging biomarkers to differentiate primary central nervous system lymphomas (PCNSLs) from high-grade gliomas (HGGs). Methods Eleven patients with lymphomas and 21 patients with HGGs were examined. Magnetization-transfer (MT) spectra over an offset range of ±6 ppm and the conventional MT ratio (MTR) at 15.6 ppm were acquired. The APTW signals, total chemical-exchange-saturation-transfer signal (integral between 0 and 5 ppm, CEST total ), and MTR signal were obtained and compared between PCNSLs and HGGs. The diagnostic performance was assessed with the receiver operating characteristic (ROC) curve analysis. Results The PCNSLs usually showed more homogeneous APTW hyperintensity (spatially compared to normal brain tissue) than the HGGs. The APTW max , APTW max-min and CEST total signal intensities were significantly lower (P<0.05, 0.001 and 0.05, respectively), while the APTW min and MTR were significantly higher (both P<0.01) in PCNSL lesions than in HGG lesions. The APTW values in peritumoral oedema were significantly lower for PCNSLs than for HGGs (P<0.01). APTW max-min had the highest area under the ROC curve (0.963) and accuracy (94.1 %) in differentiating PCNSLs from HGGs. Conclusions The protein-based APTW signal would be a valuable MRI biomarker by which to identify PCNSLs and HGGs presurgically. Key Points • PCNSLs overall showed more homogeneous APTW hyperintensity than HGGs.
Introduction
Primary central nervous system cerebral lymphoma (PCNSL) causes approximately 5 % of all primary brain tumours. Although a relatively lower incidence is found for PCNSL than for glioma, the most common malignant brain tumour, the incidence has increased drastically in both immunosuppressed and immunocompetent patients in recent decades [1, 2] . PCNSLs are usually treated by chemotherapy and wholebrain radiotherapy, while, with high-grade gliomas (HGGs), the treatment preference is a maximal safe resection, followed by chemotherapy and radiotherapy. Therefore, the precise preoperative differentiation of PCNSLs and HGGs is of significant practical relevance.
Brain MRI is a standard modality for imaging brain tumours in the clinic [3, 4] . However, there is a substantial overlap in the imaging features of PCNSLs and HGGs, both of which usually demonstrate gadolinium (Gd)-enhancing masses and surrounding oedema on traditional MR images [5] [6] [7] . In recent years, it has been reported that several functional imaging parameters, using more advanced imaging techniques, may improve the discrimination of PCNSLs and HGGs, such as the apparent diffusion coefficient derived from diffusion imaging [8] [9] [10] [11] [12] , tumour blood volume from the dynamic susceptibility contrast perfusion imaging [8, 10, 12, 13] or intravoxel incoherent motion imaging [10] , intratumoral susceptibility signals on susceptibility-weighted imaging [14] , and tumour blood flow from arterial spin labelling perfusion imaging [11, 15] . Although the results are promising, the sensitivity and specificity levels and optimal cut-off values in differentiating these two tumours reported to date have been quite variable [8] [9] [10] [11] [12] [13] [14] [15] . Currently, none of these modalities has been accepted as a gold standard for differential imaging diagnosis in the clinic.
Amide proton transfer (APT) imaging [16, 17] is a novel chemical exchange saturation transfer (CEST)-based molecular MRI technique [18] [19] [20] that detects endogenous mobile proteins and peptides in tissue, such as those dissolved in the cytoplasm. Note that semi-solid macromolecules in the more solid environment of the cell, such as those in the nucleus and the membrane, detectable by conventional magnetization transfer (MT) imaging (quantified by the MT ratio or MTR) [21] , cannot be detected by APT imaging. The significance of using APT imaging is that the MRI contrast at the cellular protein level is achieved indirectly through the bulk water signal used in daily imaging. Many encouraging results have been reported by different research groups, regarding promising APT-weighted (APTW) signals as image biomarkers for brain tumours [22] [23] [24] [25] [26] [27] and other cancers in the prostate, breast and neck [28] [29] [30] [31] , and for cerebral ischaemia [32] [33] [34] , Parkinson's disease [35] and ventral hernia [36] . To the best of our knowledge, PCNSLs have never been studied with APT imaging, and the APT-MRI parameters have also not been quantitatively compared between PCNSLs and HGGs.
In this study, we assessed the diagnostic performance of APT imaging in the differentiation of PCNSLs and HGGs, and compared the results with semi-solid MT imaging. Previous pathological reports revealed that the tumour cells of PCNSL had a high nuclear-cytoplasm (N/C) ratio and prominent nucleoli [37] [38] [39] , and thus a relatively low concentration of mobile proteins and peptides per unit tissue volume. Here, we hypothesize that the high N/C ratio and prominent nucleoli in the cells of PCNSL are associated with a relatively low APT-MRI signal and a relatively high MTR signal, compared with those of HGGs. We aimed to explore a non-invasive way of identifying PCNSLs and HGGs at the molecular level based on their APT-MRI signals.
Materials and methods

Subjects
This study was approved by the local Institutional Review Board, and all subjects gave written informed consent prior to participation in this study. Between May 2011 and July 2014, potentially eligible patients were identified on the basis of the diagnosis of PCNSLs or HGGs. Only previously untreated candidates were enrolled (excluding patients who obtained treatments, such as corticosteroid administration, operation, chemotherapy or radiotherapy), and none of the enrolled patients had neurological disorders other than a primary neoplasm. Thus, eleven PCNSL patients (six females, five males; mean age, 55.3±13.7 years; age range, 36−79 years) with 13 lesions (one patient had three separate cerebral lesions) and 21 HGG patients (14 females, seven males; mean age, 45.0±14.6 years; age range, 22− 66 years) were included in the present study. All PCNSLs and HGGs were histopathologically diagnosed, and all PCNSLs were diffuse large B-cell lymphomas. Glioma grade was determined based on the 2007 WHO criteria.
MRI protocol
All patients were scanned on a Philips 3 T MRI system (Achieva 3.0 T; Philips Medical Systems, Best, The Netherlands) using a body coil for radiofrequency transmission and an eight-channel sensitivity encoding coil for reception. The routine MRI sequences performed for each patient included (field of view (FOV), 240×240 mm 2 ; matrix, 512×512; slice thickness, 6 mm): T 1 -weighted (T 1 W), T 2 -weighted (T 2 W), fluid-attenuated inversion recovery (FLAIR), APT imaging, and gadolinium contrast-enhanced T 1 -weighted (Gd-T 1 W). Gadopentetate dimeglumine (0.2 mL/kg body weight; Magnevist; Bayer Schering, Guangzhou, China) was finally injected to acquire Gd-T 1 W images.
APT imaging was obtained using a fat-suppressed, fast spin-echo pulse sequence, with a pulse-train radiofrequency saturation (duration=200 ms×4; inter-pulse delay, 10 ms; power level=2 μT) [22, 35] . The imaging parameters used were as follows: repetition time=3 s; echo time=11 ms; sensitivity-encoding factor=2; matrix=128×64 (reconstructed to be 400×400); FOV=240×240 mm 2 ; and slice thickness= 6 mm. A multi-offset, multi-acquisition APT imaging acquisition protocol [31 offsets=0, ± 0.25, ± 0.5, ± 0.75, ± 1, ± 1.5, ± 2, ± 2.5, ± 3 (2), ± 3.25 (4), ± 3.5 (8), ± 3.75 (4), ± 4 (2), ± 4.5, ± 5, ± 6 ppm; the values in parentheses were the number of acquisitions, which was 1, if not specified] was used. The higher number of acquisitions between±3 and±4 ppm were used to increase the signal-to-noise ratio of the APTW images. In addition, a saturated image at the offset of 15.6 ppm (2 kHz) was acquired to calculate the conventional MTR value with respect to the semi-solid MT imaging, and an unsaturated image was acquired for the signal normalization. APT scans were acquired at one FLAIR image slice showing the maximum tumour area, which was based on a qualitative analysis by visual inspection by a radiologist on site. The imaging time was about 3 min.
Image analysis
All raw image data were processed using the Interactive Data Language (IDL; ITT Visual Information Solutions, Boulder, CO, USA). The MT-spectrum (the normalized saturated imaging signal intensities as a function of frequency offsets, relative to the water resonance) was organized and corrected for the B 0 field heterogeneity effect on a voxel-by-voxel basis, as reported in the literature [22] . APT imaging was quantified through the MTR asymmetry analysis with respect to the water resonance. The calculated MTR asym (3.5 ppm) image, using the B 0 -corrected MT-spectrum data at the offset of ±3.5 ppm, was usually called the APTW image (Supplementary Information) [40] . The total CEST signal intensity (CEST total ) was defined as the integral of the whole MTR asym spectrum between 0 and 5 ppm ( Supplementary  Fig. S1 ). The different acquisition numbers at different frequency offsets should not cause any problem for CEST total , which depends on image intensities, not on noises.
Regions of interest (ROIs) were carefully chosen by two experienced radiologists (S.J. and X.W., who had nine and six years of experience in brain imaging, respectively). For each patient, similar to some previous reports [12, 25, 41] , five ROIs were defined in the Gd-enhancing lesion area on the same Gd-T 1 W image slice as APT imaging (Fig. 1) . The peritumoral oedema (if present) and contralateral normalappearing white matter (CNAWM) were also analyzed. No ROIs included areas of large liquefactive necrosis, haemorrhages, or large vessels evident on standard MRI sequences. The APTW signal intensity, MTR asym spectrum, and MTR value were recorded for each ROI. The maximum APTW intensity (APTW max ), the minimum APTW intensity (APTW min ), the APTW signal heterogeneity within tumour cores (APTW max-min =APTW max -APTW min ), and the mean APTW intensity over all tumour ROIs (APTW mean ), the CEST total intensity (corresponding to the APTW max ) and the MTR value (corresponding to the APTW max ) from the lesions, as well as the APTW and the MTR values from the peritumoral oedema, were used to compare the two groups.
Histological data acquisition
One neuropathologist, blinded to the MRI features, reviewed histological samples from nine patients with PCNSL lesions and all 21 patients with HGG lesions. The histological data for the two remaining patients with PCNSL were kept at another institution and were not available for this study. Haematoxylin and eosin-stained (H&E) sections of 5-μm thick formalin fixed, paraffin-embedded tissue were examined.
The digital images captured using a microscope and a digital camera were analysed with image analysis software (Image-Pro Plus, version 6.0, Media Cybernetics, Silver Spring, MD, USA) by focusing on colour-specific features (bluestaining nuclei and pink-staining cytoplasm). One 0.044-mm 2 area of tissue was analysed for each case. The field to capture was selected in areas of solid tumour with highest cell density and with the least amount of non-neoplastic tissue, such as blood vessels, major necrotic tissue, inflammatory cells and tissue-sectioning artefacts. Furthermore, areas of the brain with single-cell tumour infiltration or reactive gliosis were avoided. The N/C ratio was calculated by dividing the nuclear area by the cytoplasmic area. 
Statistical analysis
The inter-rater agreement between the two readers for the assessment of PCNSL and HHG was analysed by using the Intraclass Correlation Coefficient (ICC) with 95 % confidence intervals (CIs) and by applying a one-way intraclass correlation coefficient with a random rater assumption. The comparisons of MRI parameters between the PCNSL and HGG groups were performed using an independent samples t-test to analyse the statistical differences. The sensitivity, specificity and accuracy for the discrimination of PCNSLs and HHGs were calculated for the image parameters that showed significant statistical differences on the previous t-test, and the corresponding optimal cut-off values were determined by a receiver operator characteristics (ROC) analysis. Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS, Version 19.0; Chicago, IL, USA). The alpha level of all tests was set at P<0.05.
Results
Comparison of APTW image features
We first assessed the radiographic features of the PCNSLs and the HGGs, using several standard (T 1 W, T 2 W, Gd-T 1 W, MTR) and APTW sequences. Figure 2 shows one example of these standard and APTW MR images for a PCNSL patient, as well as high-power photomicrographs of the corresponding H&E-stained sections. For the PCNSLs, a total of 13 lesions were observed in 11 PCNSL patients scanned, nine of which were located in the cerebral deep white matter, one in the surface of the cerebral hemisphere, two with the major lesion in the ventricle (one lesion showed no visible peritumoral oedema) and one in the cerebellar hemisphere. These lesions showed homogeneous (n=9) or to some extent heterogeneous, either fissuring necrotic (n=3) or central faint (n=1), Gd enhancements on the post-contrast T 1 W images. The APTW images overall showed visually homogenous APTW hyperintensities (spatially compared to the CNAW M) in the Gd-enhancing areas on the Gd-T 1 W images. The lesions identified by APTW were smaller than or approximately equal to those identified by T 1 W, T 2 W and MTR, but were almost equal to the lesions identified on the Gd-T 1 W images. Figure 3 shows standard and APTW MR images for two HGG patients, as well as high-power photomicrographs of the corresponding H&E-stained sections. All 21 HGG lesions (glioblastoma, n=15; anaplastic oligodendroglioma, n=2; anaplastic astrocytomas, n=4), located in the cerebral parenchyma (n=19), the cerebellar hemisphere (n =1) or the ventricle (n=1), showed considerable heterogeneous Gd enhancements (except for one case in Fig. 3b , showing slightly Gd-enhancing) on the post-contrast T 1 W images, and three lesions showed no visible peritumoral oedema. Notably, the APTW images demonstrated quite heterogeneous APTW hyperintensities (compared to the CNAWM) in the Gd-enhancing areas on the Gd-T 1 W images, showing the HGG lesions as ring-like (n=10), nodular (n=5) or patchy (n=6) heterogeneous masses. The lesions identified by APTW were smaller than or approximately equal to those identified by T 1 W, T 2 W and MTR, but larger than or approximately equal to those identified by Gd-T 1 W.
Quantitative image analysis
Inter-rater reliability, as determined by ICC, was acceptable for both PCNLs and HHGs, and there was a good consistency between raters with the ICC values of tumour APTW max , APTW min , APTW max-min , APTW mean , CEST total and MTR values of 0.982, 0.939, 0.965, 0.984, 0.951 and 0.869, respectively.
For the PCNSL and HGG lesions encircled by the Gd enhancement ( Fig. 4a and b) , the PCNSLs had significantly lower showed that the entire tumour was hypointense. APTW image showed a relatively homogeneous tumour mass, with intermediate APTW signal intensities of 2.42 %−3.04 % (compared to the CNAWM, 0.08 %). H&E-stained section showed dense aggregate cells with high N/C ratio (2.43), scanty cytoplasm, and pleomorphic nuclei of variable size, shape, staining density, and nucleolar prominence APTW max (3.38 %±1.06 %), APTW max-min (0.76 %±0.42 %), and CEST total (11.22 %±3.47 %) values than the HGGs (APTW max = 4.36 % ± 1.30 %, P < 0.05; APTW max-min = 2.55 % ±1.20 %, P < 0.01; CEST total = 14.34 % ± 4.04 %, P<0.05), and a significantly higher APTW min (2.62 %± 0.90 %) value than the HGGs (APTW min =1.81 %±0.65 % , P<0.01). It is interesting that the APTW mean showed no statistical difference between the PCNSLs (3.01 %±0.98 %) and the HGGs (3.06 %±0.81 %, P=0.879). On the contrary, the MTR value for the PCNSLs (19.22 % ±3.36 %) was significantly higher than that for the HGGs (13.43 %± 5.40 %, P<0.01).
When the peritumoral oedema areas were compared ( Fig. 4c and d) 
Discussion
In this study, we assessed the diagnostic performance of APT imaging and MT imaging to facilitate the preoperative differentiation of PCNSLs and HGGs. Our principal findings can be summarized as follows. (1) The PCNSL lesions encircled by the Gd enhancement usually demonstrated relatively homogeneous hyperintensity (spatially compared to the CNAWM), while the HGG lesions usually showed heterogeneous hyperintensity on the APTW images (Figs. 2 and 3) . (2) Quantitative image analysis showed that the PCNSL lesions demonstrated significantly lower APTW max , APTW max-min and CEST total (corresponding to the APTW max ) signals and a significantly higher APTW min signal than the HGG lesions (Fig. 4) . In addition, the mean MTR value in the PCNSL lesions (corresponding to the APTW max ) was significantly higher than that in the HGG lesions. (3) The APTW values in peritumoral oedema were significantly higher for HGGs than for PCNSLs (Fig. 4) , which may represent HGG tumour cell infiltration.
Technically, APT imaging was designed to detect mobile proteins and peptides in tissue [42] , while conventional MT imaging is sensitive to semi-solid macromolecules in the more solid environment of the cell [21] . In this study, the APTW signals (APTW max , APTW min , APTW max-min and APTW mean ), the CEST total signal, and the MTR signal were compared in two H&E-stained section showed numerous larger and richer nuclei in chromatin, accompanying with the atypical mitosis, and scanty eosinophilic fibrillary cytoplasm amidst a mucinous background. The N/C ratio was as low as 0.34. An eccentric calcification or remote haemorrhage (white arrow) was noted. The ventricle-related image artefact (black arrow) can also be seen different tumour lesions. It is well known [37] [38] [39] that the PCNSL lesions are associated with a higher N/C ratio, demonstrating less cytoplasm volume accompanied by more nuclei and membranes, compared with the HGG lesions. The significantly lower APTW max and CEST total values and significantly higher MTR value in the PCNSL group than in the HGG group were consistent with the histological characteristics of higher N/C ratios in PCNSLs, as reported in the literature [37] [38] [39] , and also verified the contrast mechanisms of APT and MTR imaging. Furthermore, the APTW max-min parameter indicated the APTW signal heterogeneity within the lesion. Unlike the HGGs, most PCNSLs, especially those in the immunocompetent patients, are histologically relatively homogenous [43, 44] . In this study, we found that the PCNSLs showed significantly lower APTW max-min than the HGGs, quite consistent with the histopathological features of the PCNSLs.
The preoperative differentiation of PCNSLs and HGGs is not always feasible with conventional or advanced MRI sequences, particularly for atypical lymphomas presenting heterogeneous contrast enhancement or for atypical glioblastomas presenting homogenous contrast enhancement (Fig. 3b) . For 32 participants in this study, the sensitivity and specificity for differentiating HGGs from PCNSLs were, respectively, 100 % and 36.4 % (by a junior radiologist, L.F., with 2 years . It is generally believed that protein-based APT imaging would be more specific than conventional water-based MRI for brain tumours. Several previous studies [22] [23] [24] [25] [26] [27] have demonstrated that the APT technique has the potential to separate high-from low-grade gliomas, the potential to differentiate between tumour and peritumoral oedema, and the potential to differentiate between tumour recurrence and treatment effects. Our early results in this study have shown that the APTW MRI signal is a valuable imaging biomarker for the differential diagnosis of HGGs and PCNSLs. Currently, APT imaging is still in its infancy. The maximal APT signal in the tumour could be 3−5 % of the bulk water intensity (Fig. 4) . Thus, APT imaging should have higher signal-to-noise ratios than some blood flow and blood volume imaging techniques, such as the arterial spin labelling imaging (about 1−2 % of the bulk water intensity) [11, 15] . Notably, one can expect that the use of a fast three-dimensional APT imaging sequence that has recently become available on clinical 3 T MRI scanners [24] would further improve the accuracy of future APTW measurements. Furthermore, it was reported that roughly 10 % of glioblastomas and 30 % of anaplastic astrocytoma demonstrate no Gd enhancement [45] . Therefore, additional MR approaches, especially those based on endogenous contrast agents, like APT imaging, are much needed. Notably, it has been shown that APTW hyperintensity is a typical feature of HGGs, independent of Gd enhancement [24] . This is particularly significant for patients with non-enhancing highgrade lesions, and for those with a contraindication to Gd administration. Therefore, the endogenous protein-based APTW image features would be a very useful MRI biomarker for assessing PCNSLs versus HGGs non-invasively and reliably. There are some limitations or weaknesses in this study.
(1) The sample size of PCNSLs was small because of the rare incidence of these tumours, and all PCNSL cases recruited in this study were immunocompetent patients. Thus, it may be difficult to determine any true optimal threshold values from this dataset. A large-scale study including both immunosuppressed and immunocompetent patients would be required to obtain more conclusive results. (2) The APT experiment covered only one slice. Thus, the MRI signal changes in other brain regions could not be evaluated in the present study. The voxel size of the APT experiment was 1.88×3.75×6 mm, which was relatively large (due to the small APT effect). This would potentially lead to homogeneous APTW hyperintensities due to the large partial volume effect. (3) No exact correspondence between pathologic specimens and the MRI sequences was obtained in this study. Therefore, the relationships between the APTW or MTR signals and N/C ratios could not be assessed quantitatively.
In conclusion, the present study represents the first analysis of the ability to use APT MRI to differentiate between PCNS Ls and HGGs. The data showed that lower APTW max , APTW max-min and CEST total , and higher APTW min and MTR are most likely be associated with a PCNSL, whereas higher APTW max , APTW max-min and CEST total and lower APTW min and MTR are most likely associated with an HGG. APTW max-min had the highest AUC and accuracy, and outperformed all other parameters in separating PCNSLs from HGGs. Our early results suggest that the endogenous proteinbased APTW signal may be a valuable MRI biomarker by which to identify PCNSLs and HGGs presurgically. APT-MRI is a safe, completely non-invasive technology, and the results can be readily translated into the clinic. The addition of APT imaging to the currently used MRI protocol (including the conventional and advanced MRI sequences) would greatly enhance the diagnostic accuracy of MRI for these brain malignancies ultimately.
